MARKET

GELS

GELS

Gelteq Limited
NASDAQ
1.140
+0.040
+3.64%
Opening 10:23 12/05 EST
OPEN
1.050
PREV CLOSE
1.100
HIGH
1.150
LOW
1.013
VOLUME
100.61K
TURNOVER
--
52 WEEK HIGH
5.50
52 WEEK LOW
0.7701
MARKET CAP
12.21M
P/E (TTM)
-2.4638
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GELS last week (1124-1128)?
Weekly Report · 4d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 11/24 17:05
Gelteq announces ‘positive’ preclinical results for its gel formulation
TipRanks · 11/24 13:45
Gelteq Announces Preclinical Results Showing That Its Proprietary Gel-Based Oral Delivery Formulation Significantly Improves The Bioavailability Of An Antihistamine Compared To A Leading Existing Product
Benzinga · 11/24 13:34
GELTEQ LTD: ANTICIPATES USING THESE RESULTS TO FURTHER PURSUE FDA APPROVAL PATHWAY FOR ANTIHISTAMINE PRODUCT
Reuters · 11/24 13:31
Weekly Report: what happened at GELS last week (1117-1121)?
Weekly Report · 11/24 10:17
Weekly Report: what happened at GELS last week (1110-1114)?
Weekly Report · 11/17 10:17
Weekly Report: what happened at GELS last week (1103-1107)?
Weekly Report · 11/10 10:14
More
About GELS
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

Webull offers Gelteq Ltd stock information, including NASDAQ: GELS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GELS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GELS stock methods without spending real money on the virtual paper trading platform.